123 related articles for article (PubMed ID: 37767820)
1. A systematic review of the normal tissue complication probability models and parameters: Head and neck cancers treated with conformal radiotherapy.
Tajiki S; Joya M; Gharekhani V; Richeson D; Gholami S
Head Neck; 2023 Dec; 45(12):3146-3156. PubMed ID: 37767820
[TBL] [Abstract][Full Text] [Related]
2. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
[TBL] [Abstract][Full Text] [Related]
3. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
4. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
[TBL] [Abstract][Full Text] [Related]
5. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
[TBL] [Abstract][Full Text] [Related]
6. Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.
Lee TF; Yeh SA; Chao PJ; Chang L; Chiu CL; Ting HM; Wang HY; Huang YJ
Radiat Oncol; 2015 Sep; 10():194. PubMed ID: 26377924
[TBL] [Abstract][Full Text] [Related]
7. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.
Lee TF; Chao PJ; Wang HY; Hsu HC; Chang P; Chen WC
BMC Cancer; 2012 Dec; 12():567. PubMed ID: 23206972
[TBL] [Abstract][Full Text] [Related]
8. Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy.
Mavroidis P; Pearlstein KA; Dooley J; Sun J; Saripalli S; Das SK; Wang AZ; Chen RC
Radiat Oncol; 2018 Feb; 13(1):17. PubMed ID: 29394931
[TBL] [Abstract][Full Text] [Related]
9. Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.
Wang Z; Chen M; Sun J; Jiang S; Wang L; Wang X; Sahoo N; Gunn GB; Frank SJ; Nguyen QN; Liao Z; Chang JY; Zhu XR; Zhang X
Radiother Oncol; 2020 May; 146():200-204. PubMed ID: 32220701
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation.
Wang D; Yin Y; Zhou Q; Li Z; Ma X; Yin Y; Li B; Bai T; Li D; Zhu J
Med Phys; 2022 Jan; 49(1):756-767. PubMed ID: 34800297
[TBL] [Abstract][Full Text] [Related]
11. Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise.
Gulliford SL; Partridge M; Sydes MR; Webb S; Evans PM; Dearnaley DP
Radiother Oncol; 2012 Mar; 102(3):347-51. PubMed ID: 22119373
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
13. Normal tissue complication probability of acute eyelids erythema following radiotherapy of head and neck cancers and skull-base tumors.
Momeni N; Ali Boroomand M; Roozmand Z; Namiranian N; Hamzian N
Phys Med; 2023 Aug; 112():102621. PubMed ID: 37329741
[TBL] [Abstract][Full Text] [Related]
14. Estimating the Dose-Response Relationship for Ocular Pain after Radiotherapy of Head and Neck Cancers and Skull Base Tumors based on the LKB Radiobiological Model.
Momeni N; Broomand MA; Roozmand Z; Hamzian N
J Biomed Phys Eng; 2023 Oct; 13(5):411-420. PubMed ID: 37868939
[TBL] [Abstract][Full Text] [Related]
15. Model development of dose and volume predictors for esophagitis induced during chemoradiotherapy for lung cancer as a step towards radiobiological treatment planning.
He R; Duggar WN; Yang CC; Vijayakumar S
BMC Pulm Med; 2023 Oct; 23(1):379. PubMed ID: 37814254
[TBL] [Abstract][Full Text] [Related]
16. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
[TBL] [Abstract][Full Text] [Related]
17. Fitting NTCP models to SBRT dose and carotid blowout syndrome data.
Mavroidis P; Grimm J; Cengiz M; Das S; Tan X; Yazici G; Ozyigit G
Med Phys; 2018 Oct; 45(10):4754-4762. PubMed ID: 30102783
[TBL] [Abstract][Full Text] [Related]
18. NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation.
Mavroidis P; Pearlstein KA; Moon DH; Xu V; Royce TJ; Weiner AA; Shen CJ; Marks LB; Chera BS; Das SK; Wang K
Radiat Oncol; 2021 Mar; 16(1):56. PubMed ID: 33743773
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationship and normal-tissue complication probability of conductive hearing loss in patients undergoing head-and-neck or cranial radiotherapy: A prospective study including 70 ears.
Mosleh-Shirazi MA; Amraee A; Mohaghegh F
Phys Med; 2019 May; 61():64-69. PubMed ID: 31151581
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.
Cambria R; Jereczek-Fossa BA; Cattani F; Garibaldi C; Zerini D; Fodor C; Serafini F; Pedroli G; Orecchia R
Strahlenther Onkol; 2009 Jun; 185(6):384-9. PubMed ID: 19506822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
